1:24cv9715 • December 17, 2024
Class Period Start
January 2, 2024
Class Period End
December 3, 2024
PSLRA Deadline
February 18, 2025
Case Allegations
10b5
Statutes of Repose
Jan 2, 2027
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
April 8, 2026
Settlement Fund
$15,480,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired the publicly traded common stock of Applied Therapeutics, Inc., (“Applied”) on a U.S. based exchange between January 3, 2024 and December 2, 2024, inclusive.
Claim Administrator
Angeion Group
1650 Arch Street, Suite 2210
Philadelphia, PA 19103
+1 833-703-4229
[email protected]
Settlement Website
https://www.apltsecuritiessettlement.com/homeHearing Date
March 19, 2026
Opt-out Deadline
February 26, 2026
Settlement Note
Download hereProof Of Claim
Download here
Mar 19, 2026
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Feb 12, 2026
Motion for Final Approval of Settlement
The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.
Dec 19, 2025
Dec 19, 2025
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Nov 20, 2025
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Nov 4, 2025
Motion for Preliminary Approval of Settlement
The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.
Jun 27, 2025
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jun 27, 2025
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jun 13, 2025
A new complaint has been filed on behalf of certain investors in Applied Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Jun 9, 2025
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
May 23, 2025
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 23, 2025
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 2, 2025
A new complaint has been filed on behalf of certain investors in Applied Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 11, 2025
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Dec 27, 2024
Another plaintiff has filed a complaint on behalf of investors in Applied Therapeutics, Inc.. The allegations and class definitions are substantively the same.
Dec 17, 2024
A securities fraud class action complaint has been filed on behalf of certain investors in Applied Therapeutics, Inc..
TOP
